Mostrando 2 resultados de: 2
Filtros aplicados
Subtipo de publicación
Article(2)
Área temáticas
Enfermedades(2)
Área de conocimiento
Medicamento(1)
Origen
scopus(2)
Long-term cardiometabolic morbidity in young adults with classic 21-hydroxylase deficiency congenital adrenal hyperplasia
ArticleAbstract: Purpose: To study the current practice for assessing comorbidity in adults with 21-hydroxylase CAH aPalabras claves:21-hydroxylase deficiency, Co-morbidities, Congenital adrenal hyperplasia, outcome, registryAutores:Ahmed S.F., Ali S.R., Bachega T.A.S.S., Baronio F., Bonfig W., Bryce J., Ceccato F., Cools M., Costa E.C., Daniel E., Falhammar H., Guaragna-Filho G., Iotova V., Markosyan R., Miranda M.C., Richard J. Auchus, Righi B., Ross R.J., Russo G., Stancampiano M.R., Tomlinson J.W., T’Sjoen G.Fuentes:scopusTreatment patterns and unmet needs in adults with classic congenital adrenal hyperplasia: A modified Delphi consensus study
ArticleAbstract: Background: Classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is a rarePalabras claves:classic CAH, classic congenital adrenal hyperplasia, glucocorticoid management, treatment complication, unmet needsAutores:Anatchkova M., Courtillot C., Cutts K., Dobs A., El-Maouche D., Falhammar H., Farrar M., Lacroix A., Lamotte M., O’Donoghue C., Richard J. Auchus, Taylor N., Touraine P., Yonan C.Fuentes:scopus